Veracyte, Inc. (NASDAQ:VCYT – Get Rating) Director Muna Bhanji sold 5,893 shares of the firm’s stock in a transaction dated Friday, June 16th. The shares were sold at an average price of $26.44, for a total transaction of $155,810.92. Following the completion of the transaction, the director now directly owns 28,514 shares in the company, […]
AEGON ASSET MANAGEMENT UK Plc lowered its stake in Veracyte, Inc. (NASDAQ:VCYT – Get Rating) by 20.0% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 363,075 shares of the biotechnology company’s stock after selling 90,928 shares during the […]
AEGON ASSET MANAGEMENT UK Plc lessened its holdings in shares of Veracyte, Inc. (NASDAQ:VCYT – Get Rating) by 20.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 363,075 shares of the biotechnology company’s stock after selling 90,928 shares during […]
Veracyte, Inc. (NASDAQ:VCYT – Get Rating) Director Muna Bhanji sold 5,893 shares of the firm’s stock in a transaction dated Friday, June 16th. The shares were sold at an average price of $26.44, for a total value of $155,810.92. Following the sale, the director now directly owns 28,514 shares in the company, valued at approximately […]
Findings presented at ENDO 2023 also confirm analytical validity of company’s TERT promoter gene mutation testing for thyroid nodule patients
. | June 20, 2023